NOTICES: National Institute of Allergy and Infectious Diseases,
Published: 2007-12-04
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Child Health and Human Development,
Published: 2007-12-04
Notice is hereby given of a change in the meeting of the National
Institute of Child Health and Human Development Special Emphasis Panel,
December 4, 2007, 1 p.m. to December 4, 2007, 5 p.m., National
Institutes of Health, 6100 Executive Boulevard, 5B01, Rockville, MD,
20852 which was published in the Federal Register on November 16, 2007,
72
RULES: Optional State plan case management services,
Published: 2007-12-04
This interim final rule with comment period revises current
Medicaid regulations to incorporate changes made by section 6052 of the
Deficit Reduction Act of 2005. In addition, it incorporates provisions
of the Consolidated Omnibus Budget Reconciliation Act of 1985, the
Omnibus Budget Reconciliation Act of 1986, the Tax Reform Act of 1986,
the
NOTICES: National Institute of General Medical Sciences,
Published: 2007-12-04
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
RULES: Physicians’ referrals to health care entities with which they have financial relationships (Phase III); Correction,
Published: 2007-12-04
This document corrects technical and typographical errors that
appeared in the final rule published in the Federal Register on
September 5, 2007 entitled ``Medicare Program, Physicians'' Referrals
to Health Care Entities With Which They Have Financial Relationships
(Phase III).''
NOTICES: National Institute of Mental Health,
Published: 2007-12-04
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Mental Health Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special
RULES: Current good manufacturing practices—; Finished pharmaceuticals,
Published: 2007-12-04
The Food and Drug Administration (FDA) is amending certain
regulations as the first phase of an incremental approach to modifying
the current good manufacturing practice (CGMP) regulations for finished
pharmaceuticals. We are amending the regulations to modernize or
clarify some of the CGMP requirements, as well as harmonize some of the
CGMP
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-04
Title: Building Strong Families (BSF) Demonstration and EvaluationImpact Study Second Followup.
OMB No.: New Collection.
Description: The Administration for Children and Families (ACF),
U.S. Department of Health and Human Services (HHS), is proposing a data
collection activity as part of the Building Strong Families (BSF)
Demonstration
NOTICES: National Institute of Neurological Disorders and Stroke,
Published: 2007-12-04
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
PROPOSED RULES: Current good manufacturing practices—; Finished pharmaceuticals,
Published: 2007-12-04
The Food and Drug Administration (FDA) is publishing this
companion proposed rule to the direct final rule, published elsewhere
in this issue of the Federal Register, which is intended to amend
certain sections of the regulations as the first phase of an
incremental approach to modifying the current good manufacturing
practice (CGMP) regulations
NOTICES: National Institute on Aging,
Published: 2007-12-04
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
PROPOSED RULES: Finished pharmaceuticals; manufacturing, quality control, and documentation requirements; withdrawn,
Published: 2007-12-04
The Food and Drug Administration (FDA) is announcing the [[Page 68112]]
withdrawal of a proposed rule published in the Federal Register of May
3, 1996 (61 FR 20103) (the May 1996 proposed rule). The May 1996
proposed rule would have amended certain requirements of the current
good manufacturing practice (CGMP) regulations for finished
NOTICES: National Institute of Mental Health strategic plan,
Published: 2007-12-04
The National Institute of Mental Health (NIMH) is developing a
strategic plan for the next 35 years, and invites the public to
provide comments on a draft of this plan. The draft plan will be
publicly available through the NIMH Draft Strategic Plan Web page
(
NOTICES: DSM Nutritional Products, Inc.,
Published: 2007-12-04
The Food and Drug Administration (FDA) is announcing that DSM
Nutritional Products, Inc., has filed a petition proposing that the
color additive regulations be amended to provide for the safe use of
astaxanthin dimethyldisuccinate as a color additive in the feed of
salmonid fish to enhance the color of their flesh.
NOTICES: Federal agency urine drug testing; certified laboratories meeting minimum standards; list,
Published: 2007-12-04
The Department of Health and Human Services (HHS) notifies
Federal agencies of the laboratories currently certified to meet the
standards of Subpart C of the Mandatory Guidelines for Federal
Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory
Guidelines were first published in the Federal Register on April 11,
1988 (53 FR 11970),
